[与性结肠炎相关的致癌:一个更新]
Daniela E Aust1, Gustavo B Baretton2, Ulrich Sommer2
1Institut für Pathologie, Universitätsklinikum Carl Gustav Carus Dresden an der TU Dresden, Fetscherstr. 74, 01307, Dresden, Deutschland. daniela.aust@ukdd.de.
Pathologie (Heidelberg, Germany)
|June 13, 2023
概括
性结肠炎 (UC) 患者面临着更高的结肠直肠癌 (CRC) 风险. 与UC相关的CRC通过炎症和肠道内膜的遗传变化而发展,影响预防和治疗策略.
科学领域:
- 胃肠道学和瘤学
- 炎症性肠道疾病研究研究
背景情况:
- 性结肠炎 (UC) 是一种慢性炎症性肠病,其原因尚不完全理解.
- UC涉及影响疾病进展的遗传,微生物,免疫和环境因素.
- 患有UC的患者患结直肠癌 (CRC) 的风险较高.
研究的目的:
- 总结有关UC相关癌变的当前知识.
- 讨论UC相关CRC的预防和治疗的影响.
主要方法:
- 关于UC相关癌症发生的文献综述.
- 分析UC相关CRC中的风险因素和分子途径.
- 与UC相关的CRC发展与零星CRC的比较.
主要成果:
- 在UC中CRC的风险与早期发病,疾病持续时间,程度,狭窄,瘤和PSC相关.
- 与UC相关的CRC遵循一个炎症 - 内皮层瘤 - 癌症序列.
- 与UC相关的CRC的遗传变化起源于炎症的表皮.
结论:
- 早期发现和管理UC对于减轻CRC风险至关重要.
- 了解UC致癌途径可以为有针对性的预防和治疗策略提供信息.
- 对UC相关癌症的进一步研究可能会导致新的治疗方法.
更多相关视频
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
227
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
227
Drugs for Treatment of Ulcerative Colitis in IBD
179
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
179
Peptic Ulcer Disease I: Introduction
217
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
217
Inflammatory Bowel Disease V: Surgical Management
174
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
174
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
362
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
362
Peptic Ulcer Disease II: Pathophysiology
575
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
575


